Considering the physiological importance of GLP-1 in controlling islet cell function, appetite, inflammation and cardiovascular pathophysiology, the development of GLP-1 receptor (GLP-1R) agonists was a crucial step in obesity and diabetes treatment strategies [192]. Here, GCG is linked to obesity due to melanocortin 4 receptor deficiency.